Mutant RNF43 almost exclusively occurs along with abnormal KRAS (Figure 6) and therefore, KRAS mutation is likely required for RNF43 mutation‐associated pancreatic cancer development. The gene discussed is RNF43; the disease is familial pancreatic carcinoma.